Substance evaluation - CoRAP

Substance evaluation - CoRAP

Substance evaluation - CoRAP

If a substance is on this list, it means that a Member State has evaluated or will evaluate it over the coming years. The list is called the Community rolling action plan (CoRAP).

For each substance, the table shows the evaluating Member State, the (planned) year of evaluation and a short description of the concern which led to it being placed on the list.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information.  Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
Suspected PMT/vPvM: Potentially Persistent, Mobile and Toxic/very Persistent and very Mobile.
CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
RCR: Risk Characterisation Ratio 

Last updated 15 March 2024. Database contains 392 unique substances/entries.
Filter the list
Initial grounds for concern:

The List does not contain any Substances.
 
215-535-7
1330-20-7
Germany
Suspected CMR
Suspected Sensitiser
Consumer use
Cumulative exposure
High (aggregated) tonnage
High RCR
Wide dispersive use
Withdrawn
Details
203-929-1
112-03-8
Italy
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Withdrawn
Details
204-857-3
127-68-4
Ireland
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
Withdrawn
Details
905-588-0
-
Germany
Suspected Reprotoxic
Suspected Sensitiser
Other hazard based concern
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Withdrawn
Details
905-562-9
-
Germany
Suspected Reprotoxic
Suspected Sensitiser
Other hazard based concern
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Withdrawn
Details
701-241-0, 906-390-7
-
Italy
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Withdrawn
Details
203-686-1
109-60-4
Ireland
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Withdrawn
Details
201-344-6
81-33-4
Belgium
Suspected PBT/vPvB
Withdrawn
Details
204-500-1
121-82-4
Hungary
Suspected Carcinogenic
Suspected Reprotoxic
Exposure of environment
Exposure of workers
Wide dispersive use
Withdrawn
Details
225-716-2
5026-74-4
Denmark
Suspected Mutagenic
Suspected Sensitiser
Consumer use
Exposure of workers
Withdrawn
Details
271-846-8
68609-97-2
Ireland
Suspected Mutagenic
Sensitiser
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Withdrawn
Details
220-260-0
2691-41-0
Hungary
Suspected Carcinogenic
Suspected Reprotoxic
Exposure of environment
Exposure of workers
Wide dispersive use
Withdrawn
Details
629-767-5
1228186-18-2
Germany
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Withdrawn
Details
432-520-2
232938-43-1
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Withdrawn
Details
249-535-3
29253-36-9
Austria
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Withdrawn
Details
701-057-0
-
Germany
Suspected PBT/vPvB
Exposure of environment
High RCR
Wide dispersive use
Withdrawn
Details
272-902-4
68919-76-6
Germany
Suspected PBT/vPvB
Exposure of environment
Withdrawn
Details
204-399-4
120-47-8
Germany
Potential endocrine disruptor
Withdrawn
Details
205-117-2
133-66-4
Italy
Suspected PBT/vPvB
Wide dispersive use
Withdrawn
Details
278-355-8
75980-60-8
Sweden
Reprotoxic
Potential endocrine disruptor
Withdrawn
Details
234-126-4
10544-72-6
Latvia
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
High RCR
Withdrawn
Details
214-189-4
1112-39-6
Belgium
Reprotoxic
Other hazard based concern
Exposure of workers
Withdrawn
Details
233-072-9
10028-22-5
Lithuania
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Withdrawn
Details
215-150-4
1306-38-3
Germany
Suspected Carcinogenic
Suspected Mutagenic
Other hazard based concern
Cumulative exposure
Exposure of environment
Wide dispersive use
Withdrawn
Details
218-747-8
2224-33-1
Italy
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Withdrawn
Details
245-366-4
22984-54-9
Italy
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Withdrawn
Details
609-946-4
41637-38-1
Germany
Suspected PBT/vPvB
Exposure of environment
Withdrawn
Details
204-262-9
118-58-1
Germany
Potential endocrine disruptor
Withdrawn
Details
931-292-6
308062-28-4
Ireland
Suspected Reprotoxic
Other hazard based concern
Withdrawn
Details
251-020-3
32388-55-9
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
Withdrawn
Details
701-276-1
-
Estonia
CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Withdrawn
Details
233-593-1
10254-57-6
Germany
Suspected PBT/vPvB
Withdrawn
Details
204-633-5
123-51-3
Poland
Suspected Carcinogenic
Suspected Reprotoxic
Suspected Sensitiser
Consumer use
Exposure of workers
Withdrawn
Details
264-727-7
64194-22-5
Slovenia
Suspected Carcinogenic
Exposure of workers
Wide dispersive use
Withdrawn
Details
242-016-2
18127-01-0
Sweden
Suspected Reprotoxic
Withdrawn
Details
200-657-5
67-51-6
Spain
Reprotoxic
High RCR
Withdrawn
Details
221-975-0
3302-10-1
Spain
Suspected Reprotoxic
Exposure of workers
Withdrawn
Details
204-263-4
118-60-5
Germany
Potential endocrine disruptor
Withdrawn
Details
248-227-6
27107-89-7
Netherlands
Potential endocrine disruptor
Withdrawn
Details
200-076-7
51-03-6
Sweden
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Withdrawn
Details
226-866-1
5521-31-3
Belgium
Suspected PBT/vPvB
Withdrawn
Details
622-542-2
3891-98-3
Austria
Suspected Mutagenic
Suspected PBT/vPvB
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Withdrawn
Details
253-057-0
36483-57-5
Denmark
Suspected Carcinogenic
Suspected Mutagenic
Withdrawn
Details
700-604-0
947701-81-7
Finland
Suspected PBT/vPvB
Consumer use
Withdrawn
Details
701-029-8
-
Estonia
CMR
Sensitiser
Consumer use
Wide dispersive use
Withdrawn
Details
217-496-1
1873-88-7
Norway
Suspected PBT/vPvB
Withdrawn
Details
241-867-7
17928-28-8
Norway
Suspected PBT/vPvB
Wide dispersive use
Withdrawn
Details
247-156-8
25640-78-2
Germany
Suspected PBT/vPvB
Wide dispersive use
Withdrawn
Details
214-263-6
1118-46-3
2018
France
Suspected Mutagenic
Suspected Reprotoxic
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Suspended
Details
237-695-7
13927-71-4
2020
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of workers
Suspended
Details
260-828-5
57583-34-3
2015
Netherlands
CMR
High (aggregated) tonnage
Suspended
Details
229-355-1
6486-23-3
2019
Italy
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Suspended
Details
228-768-4
6358-31-2
2019
Italy
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Suspended
Details
215-222-5
1314-13-2
2017
Germany
Other hazard based concern
Consumer use
Exposure of environment
Other exposure/risk based concern
Wide dispersive use
Ongoing
Details
701-028-2
-
2013
France
Suspected PBT/vPvB
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
222-020-0
3319-31-1
2012
Austria
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
484-450-7
-
2019
Spain
Suspected PBT/vPvB
Ongoing
Details
BENZTRIAZOL UV ABSORBER BUK 4499; BUK 4499; UV ABSORBER BUK 4499
403-080-9
92484-48-5
2023
Spain
Suspected PMT/vPvM
Other hazard based concern
Consumer use
Cumulative exposure
Exposure of environment
Other exposure/risk based concern
Wide dispersive use
Ongoing
Details
939-505-4
-
2023
France
Potential endocrine disruptor
Exposure of environment
Ongoing
Details
700-161-3
-
2013
Netherlands
Suspected PBT/vPvB
Ongoing
Details
422-270-2
163702-08-7
2019
Spain
Suspected PBT/vPvB
Ongoing
Details
205-031-5
131-57-7
2014
Denmark
Potential endocrine disruptor
Cumulative exposure
Exposure of environment
Exposure of sensitive populations
Exposure of workers
Wide dispersive use
Ongoing
Details
202-870-9
100-61-8
2023
Poland
Suspected Carcinogenic
Suspected Mutagenic
Cumulative exposure
Exposure of workers
High RCR
Wide dispersive use
Ongoing
Details
267-636-0
67905-17-3
2019
Belgium
Suspected PBT/vPvB
Ongoing
Details
221-374-3
3081-01-4
2012
Austria
Suspected PBT/vPvB
Wide dispersive use
Ongoing
Details
251-118-6
32588-76-4
2017
Norway
Suspected PBT/vPvB
Other hazard based concern
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Ongoing
Details
202-046-9
91-17-8
2012
Finland
Suspected PBT/vPvB
High (aggregated) tonnage
Ongoing
Details
203-628-5
108-90-7
2023
Netherlands
Suspected Mutagenic
Suspected Reprotoxic
Potential endocrine disruptor
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
308-662-5
98171-53-0
2023
France
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Exposure of environment
Exposure of workers
Ongoing
Details
203-372-4
106-20-7
2019
Portugal
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
810-801-4
-
2015
Netherlands
Suspected CMR
Suspected PBT/vPvB
High (aggregated) tonnage
Ongoing
Details
270-128-1
68411-46-1
2016
Germany
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
300-340-2
93925-38-3
2023
Sweden
Potential endocrine disruptor
Consumer use
Exposure of environment
Exposure of sensitive populations
Exposure of workers
Wide dispersive use
Ongoing
Details
484-410-9
-
2019
Spain
Suspected PBT/vPvB
Ongoing
Details
229-419-9
6528-34-3
2019
Italy
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
204-881-4
128-37-0
2016
France
Potential endocrine disruptor
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
216-475-4
1594-08-7
2019
Belgium
Suspected PBT/vPvB
Ongoing
Details
237-159-2
13674-87-8
2024
Germany
Potential endocrine disruptor
Not started
Details
205-739-4
149-44-0
2025
Netherlands
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
905-459-9
-
2024
France
Suspected Reprotoxic
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Not started
Details
The complex combination of hydrocarbons produced by the distillation of products from the hydrogenation of isononanal. It consists predominantly of C6 olefins and paraffins and C9 alcohols and aldehydes and boiling in the range of approximately 110°C to 202°C (230°F to 396°F).
273-110-1
68938-03-4
2025
Slovenia
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Not started
Details
941-303-6
-
2025
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Not started
Details
212-791-1
870-08-6
2024
Austria
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
200-467-2
60-29-7
2025
France
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
215-609-9
1333-86-4
2025
France
Carcinogenic
Suspected Reprotoxic
Consumer use
Cumulative exposure
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
218-487-5
2162-74-5
2024
Italy
Suspected PBT/vPvB
Exposure of workers
Wide dispersive use
Not started
Details
931-700-2
-
2025
France
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
202-860-4
100-52-7
2024
France
Suspected Mutagenic
Consumer use
Exposure of workers
Wide dispersive use
Not started
Details
247-118-0
25584-83-2
2025
France
Suspected Carcinogenic
Suspected Mutagenic
Suspected Sensitiser
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Wide dispersive use
Not started
Details
CD 28-0132; IRGALUBE 232
421-820-9
192268-65-8
2024
Netherlands
Suspected PBT/vPvB
Not started
Details
D-8; DD-8
405-520-5
95235-30-6
2025
Belgium
Potential endocrine disruptor
Other exposure/risk based concern
Not started
Details
244-815-1
22174-70-5
2024
Ireland
Suspected Reprotoxic
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Not started
Details
1 - 4.5 moles ethoxylated
500-082-2
32492-61-8
2025
France
Suspected Mutagenic
Potential endocrine disruptor
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
202-826-9
100-18-5
2024
France
Suspected Reprotoxic
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Exposure of workers
Not started
Details
202-773-1
99-62-7
2024
France
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Not started
Details
205-288-3
137-30-4
2012
Denmark
Potential endocrine disruptor
High RCR
Information requested
Details
236-675-5
13463-67-7
2018
France
Carcinogenic
Suspected Mutagenic
Other hazard based concern
Information requested
Details
203-585-2
108-46-3
2019
France
Potential endocrine disruptor
High (aggregated) tonnage
Information requested
Details
264-848-5
64365-17-9
2015
Finland
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
701-385-4
-
2021
France
Suspected Mutagenic
Suspected PBT/vPvB
High (aggregated) tonnage
Information requested
Details

Export search results to: